These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. SARS-CoV-2 Antibody Testing in Health Care Workers: A Comparison of the Clinical Performance of Three Commercially Available Antibody Assays. Allen N; Brady M; Carrion Martin AI; Domegan L; Walsh C; Houlihan E; Kerr C; Doherty L; King J; Doheny M; Griffin D; Molloy M; Dunne J; Crowley V; Holmes P; Keogh E; Naughton S; Kelly M; O'Rourke F; Lynagh Y; Crowley B; de Gascun C; Holder P; Bergin C; Fleming C; Ni Riain U; Conlon N; Microbiol Spectr; 2021 Oct; 9(2):e0039121. PubMed ID: 34585976 [TBL] [Abstract][Full Text] [Related]
3. Validation of Commercial SARS-CoV-2 Immunoassays in a Nigerian Population. Ige F; Hamada Y; Steinhardt L; Iriemenam NC; Uwandu M; Greby SM; Aniedobe M; Salako BL; Rangaka MX; Abubakar I; Audu R Microbiol Spectr; 2021 Oct; 9(2):e0068021. PubMed ID: 34612691 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Surrogate Enzyme-Linked Immunosorbent Assay-Based Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) cPass Neutralization Antibody Detection Assay and Correlation With Immunoglobulin G Commercial Serology Assays. Nandakumar V; Profaizer T; Lozier BK; Elgort MG; Larragoite ET; Williams ESCP; Solis-Leal A; Lopez JB; Berges BK; Planelles V; Rychert J; Slev PR; Delgado JC Arch Pathol Lab Med; 2021 Oct; 145(10):1212-1220. PubMed ID: 34181714 [TBL] [Abstract][Full Text] [Related]
7. An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population. Wehrhahn MC; Brown SJ; Newcombe JP; Chong S; Evans J; Figtree M; Hainke L; Hueston L; Khan S; Marland E; O'Sullivan MVN; Powell H; Roy J; Waring L; Yu M; Robson J J Clin Virol; 2021 May; 138():104797. PubMed ID: 33770657 [TBL] [Abstract][Full Text] [Related]
8. Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Guo L; Wang Y; Kang L; Hu Y; Wang L; Zhong J; Chen H; Ren L; Gu X; Wang G; Wang C; Dong X; Wu C; Han L; Wang Y; Fan G; Zou X; Li H; Xu J; Jin Q; Cao B; Wang J Emerg Microbes Infect; 2021 Dec; 10(1):664-676. PubMed ID: 33734013 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of a multiplexed coronavirus antigen array for detection of SARS-CoV-2 specific IgG in COVID-19 convalescent plasma. Huey L; Andersen G; Merkel PA; Morrison TE; McCarthy M; DomBourian MG; Annen K; Dawson ED; Rowlen KL; Knight V J Immunol Methods; 2021 Oct; 497():113104. PubMed ID: 34303688 [TBL] [Abstract][Full Text] [Related]
10. Diagnostic and analytical performance evaluation of ten commercial assays for detecting SARS-CoV-2 humoral immune response. Mylemans M; Van Honacker E; Nevejan L; Van Den Bremt S; Hofman L; Poels J; Cattoir L; Boel A; Van Hoovels L J Immunol Methods; 2021 Jun; 493():113043. PubMed ID: 33773989 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of five widely used serologic assays for antibodies to SARS-CoV-2. Stocking C; de Miguel L; Suteu G; Dressel A; Soricelli A; Roskos M; Valor S; Mutschmann C; März W Diagn Microbiol Infect Dis; 2022 Feb; 102(2):115587. PubMed ID: 34826767 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays. Harley K; Gunsolus IL J Clin Microbiol; 2020 Dec; 59(1):. PubMed ID: 33106364 [TBL] [Abstract][Full Text] [Related]
14. Performance of SARS-CoV-2 serology tests: Are they good enough? Piec I; English E; Thomas MA; Dervisevic S; Fraser WD; John WG PLoS One; 2021; 16(2):e0245914. PubMed ID: 33596236 [TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 Serologic Assays in Control and Unknown Populations Demonstrate the Necessity of Virus Neutralization Testing. Rathe JA; Hemann EA; Eggenberger J; Li Z; Knoll ML; Stokes C; Hsiang TY; Netland J; Takehara KK; Pepper M; Gale M J Infect Dis; 2021 Apr; 223(7):1120-1131. PubMed ID: 33367830 [TBL] [Abstract][Full Text] [Related]
16. Limited specificity of commercially available SARS-CoV-2 IgG ELISAs in serum samples of African origin. Emmerich P; Murawski C; Ehmen C; von Possel R; Pekarek N; Oestereich L; Duraffour S; Pahlmann M; Struck N; Eibach D; Krumkamp R; Amuasi J; Maiga-Ascofaré O; Rakotozandrindrainy R; Asogun D; Ighodalo Y; Kann S; May J; Tannich E; Deschermeier C Trop Med Int Health; 2021 Jun; 26(6):621-631. PubMed ID: 33666297 [TBL] [Abstract][Full Text] [Related]
17. Anti-SARS-CoV-2 IgM improves clinical sensitivity early in disease course. Higgins V; Fabros A; Wang XY; Bhandari M; Daghfal DJ; Kulasingam V Clin Biochem; 2021 Apr; 90():1-7. PubMed ID: 33476578 [TBL] [Abstract][Full Text] [Related]